2023

Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II Trial
Flaadt T, Ladenstein R, Ebinger M, Lode H, Arnardóttir H, Poetschger U, Schwinger W, Meisel R, Schuster F, Döring M, Ambros P, Queudeville M, Fuchs J, Warmann S, Schäfer J, Seitz C, Schlegel P, Brecht I, Holzer U, Feuchtinger T, Simon T, Schulte J, Eggert A, Teltschik H, Illhardt T, Handgretinger R, Lang P
J CLIN ONCOL. 2023;41(17):3135-3148.

Evaluating the safety of perioperative dexamethasone treatment: A retrospective analysis of a single center pediatric low-grade glioma cohort
Gorodezki D, Zipfel J, Queudeville M, Holzer U, Bevot A, Schittenhelm J, Nägele T, Schuhmann M, Ebinger M
INT J CANCER. 2023;152(9):1875-1883.

Low leukemia burden improves blinatumomab efficacy in patients with relapsed/refractory B-cell acute lymphoblastic leukemia
Queudeville M, Stein A, Locatelli F, Ebinger M, Handgretinger R, Gökbuget N, Gore L, Zeng Y, Gokani P, Zugmaier G, Kantarjian H
CANCER-AM CANCER SOC. 2023;129(9):1384-1393.

Th1 cytokines in pediatric acute lymphoblastic leukemia
Schober S, Rottenberger J, Hilz J, Schmid E, Ebinger M, Feuchtinger T, Handgretinger R, Lang P, Queudeville M
CANCER IMMUNOL IMMUN. 2023;72(11):3621-3634.

2022

The role of γδ T cells in the context of allogeneic stem cell transplantation
Handgretinger R, Lang P, Queudeville M
Exploration of Immunology. 2022.

Introducing isotonic fluids into pediatric oncology
Heinz A, Eichholz T, Queudeville M, Hartmann U, Ott A, Heinzel O, Handgretinger R, Ebinger M
PEDIATR HEMAT ONCOL. 2022;39(4):357-364.

2021

Blinatumomab in Pediatric Acute Lymphoblastic Leukemia—From Salvage to First Line Therapy (A Systematic Review)
Queudeville M, Ebinger M
J CLIN MED. 2021.

Blinatumomab in pediatric patients with relapsed/refractory B‐cell precursor acute lymphoblastic leukemia
Queudeville M, Schlegel P, Heinz A, Lenz T, Döring M, Holzer U, Hartmann U, Kreyenberg H, Stackelberg A, Schrappe M, Zugmaier G, Feuchtinger T, Lang P, Handgretinger R, Ebinger M
EUR J HAEMATOL. 2021.

An Fc-Optimized CD133 Antibody for Induction of NK Cell Reactivity against B Cell Acute Lymphoblastic Leukemia
Riegg F, Lutz M, Schmied B, Heitmann J, Queudeville M, Lang P, Jung G, Salih H, Märklin M
CANCERS. 2021.

2020

<p>Antiemetic Prophylaxis with Fosaprepitant and 5-HT₃-Receptor Antagonists in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation</p>
Stanchi K, Willier S, Vek J, Schlegel P, Queudeville M, Rieflin N, Klaus V, Gansel M, Rupprecht J, Flaadt T, Binder V, Feuchtinger T, Lang P, Handgretinger R, Döring M
DRUG DES DEV THER. 2020.

Letzte Aktualisierung aus dem FIS: 21.02.2026 - 05:27 Uhr